Why breast cancer researchers are paying attention Weight and metabolic health matter in breast cancer because excess body fat is linked to higher risk of developing breast cancer after menopause, and it may also affect recurrence, treatment tolerance, and long-term outcomes
Prof Jason Halford, president of the European Association for the Study of Obesity, said that as the medication could be seen to improve cardiovascular health, it could be economically beneficial for it to be prescribed widely
Patients may experience difficulty procuring the medication from their local or online pharmacies
This innovative molecule not only captivates the GLP-1 receptors but also charms the GIP (Glucose-dependent Insulinotropic Polypeptide) receptors, creating a weight loss power couple that leaves the audience mesmerized
A large Swedish study published in 2018 analysed over 100,000 patients and found no association between GLP-1 receptor agonist use and pancreatic cancer
Semaglutide is powerful, but it does not specifically provide vitamins or minerals